Vevo Therapeutics has officially launched out of stealth today with an oversubscribed and upsized $12M seed financing. We are so excited to reveal what we have been building behind the scenes! 🧵1/6
vevo.ai/#news
vevo.ai/#news
We're building the world’s largest in vivo, single-cell atlas of how drugs interact with patient cells. Combining this atlas with next-gen #AI, we aim to capture in vivo context of disease at the first step of discovery & better represent #PatientDiversity in drug response 2/6
What does this mean for patients? Better targets that would otherwise be missed, and drugs that are more likely to treat more patients. 3/6
Our team includes engineers and scientists that have drugged the undruggable and invented novel methods in #genomics, #ComputationalBiology, and #ComputationalChemistry
@nalidoust, @genophoria, @iamjohnnyyu, @kevansf 4/6
@nalidoust, @genophoria, @iamjohnnyyu, @kevansf 4/6
We’re proud to be backed by prominent investors who believe in our mission, including @Wing_VC, @generalcatalyst , @Mubadala , @aixventureshq and @Camford_Capital 5/6
Visit our website at vevo.ai and follow our page for more updates as we reshape the way drug discovery is done. #BiotechNews #Biotechnology #VevoTherapeutics 6/6
• • •
Missing some Tweet in this thread? You can try to
force a refresh
